Cite
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
MLA
Pfeffer, M. A., et al. “Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.” New England Journal of Medicine, vol. 385, no. 20, Nov. 2021, pp. 1845–55. EBSCOhost, https://doi.org/10.1056/NEJMoa2104508.
APA
Pfeffer, M. A., Claggett, B., Lewis, E. F., Granger, C. B., Kober, L., Maggioni, A. P., Mann, D. L., McMurray, J. J. V., Rouleau, J.-L., Solomon, S. D., Steg, P. G., Berwanger, O., Cikes, M., De Pasquale, C. G., East, C., Fernandez, A., Jering, K., Landmesser, U., Mehran, R., & Merkely, B. (2021). Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. New England Journal of Medicine, 385(20), 1845–1855. https://doi.org/10.1056/NEJMoa2104508
Chicago
Pfeffer, M. A., B. Claggett, E. F. Lewis, C. B. Granger, L. Kober, A. P. Maggioni, D. L. Mann, et al. 2021. “Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.” New England Journal of Medicine 385 (20): 1845–55. doi:10.1056/NEJMoa2104508.